Artal Group Sa Has Lifted Its Metlife INC (Call) (MET) Position by $53.00 Million; Market Value Declined

July 18, 2017 - By Ellis Scott

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.01, from 0.93 in 2016Q3. It increased, as 69 investors sold MET shares while 359 reduced holdings. 122 funds opened positions while 279 raised stakes. 810.29 million shares or 2.96% more from 786.98 million shares in 2016Q3 were reported. 13,497 were accumulated by Hudson Valley Invest Advisors Inc Adv. Ftb Advsrs has invested 0.74% in Metlife Inc (NYSE:MET). Stephens Ar invested in 47,026 shares. Fiera Capital reported 40,800 shares or 0.01% of all its holdings. Rnc Limited Liability Co invested 1.74% of its portfolio in Metlife Inc (NYSE:MET). Guggenheim Cap Limited Liability Corporation, a Illinois-based fund reported 1.07 million shares. Regentatlantic Capital has 180,926 shares. 1832 Asset Lp accumulated 900 shares or 0% of the stock. Janney Montgomery Scott Limited Liability Corporation has 0.42% invested in Metlife Inc (NYSE:MET) for 512,125 shares. Tocqueville Asset Lp owns 0.24% invested in Metlife Inc (NYSE:MET) for 348,218 shares. 130,820 were reported by Montag A And Assoc. Wade G W & holds 130,232 shares. Legal General Grp Public Ltd reported 4.56 million shares. Virtus Advisers Inc owns 104,555 shares. 42 were reported by Hartford Management.

Artal Group Sa increased its stake in Metlife Inc (Call) (MET) by 133.33% based on its latest 2016Q4 regulatory filing with the SEC. Artal Group Sa bought 1.00 million shares as the company’s stock declined 4.70% while stock markets rallied. The institutional investor held 1.75 million shares of the finance company at the end of 2016Q4, valued at $94.31 million, up from 750,000 at the end of the previous reported quarter. Artal Group Sa who had been investing in Metlife Inc (Call) for a number of months, seems to be bullish on the $59.56B market cap company. The stock 0.01% or $0 on July 17, reaching $55.35. It is down 13.92% since July 18, 2016 and is uptrending. It has underperformed by 2.78% the S&P500.

Artal Group Sa, which manages about $4.50 billion US Long portfolio, decreased its stake in Biomarin Pharmaceutical Inc (Call) (NASDAQ:BMRN) by 150,000 shares to 150,000 shares, valued at $12.43 million in 2016Q4, according to the filing. It also reduced its holding in Alibaba Group Hldg Ltd (NYSE:BABA) by 50,000 shares in the quarter, leaving it with 250,000 shares, and cut its stake in Array Biopharma Inc (NASDAQ:ARRY).

More notable recent Metlife Inc (NYSE:MET) news were published by: Reuters.com which released: “MetLife board approves Brighthouse spinoff, sets effective date” on June 29, 2017, also Bloomberg.com with their article: “MetLife Sees Fortress Deal as ‘Jump Start’ for Asset Management” published on July 11, 2017, Reuters.com published: “MetLife seeks new delay in ‘too big to fail’ case to wait for Trump” on July 06, 2017. More interesting news about Metlife Inc (NYSE:MET) were released by: Insurancenewsnet.com and their article: “MetLife Board Approves Spin-Off Of Brighthouse Financial” published on June 29, 2017 as well as Reuters.com‘s news article titled: “MetLife says to buy bond fund manager Logan Circle for $250 million” with publication date: July 07, 2017.

Metlife Inc (NYSE:MET) Ratings Coverage

Among 13 analysts covering MetLife (NYSE:MET), 8 have Buy rating, 1 Sell and 4 Hold. Therefore 62% are positive. MetLife has $65.0 highest and $46 lowest target. $54.13’s average target is -2.20% below currents $55.35 stock price. MetLife had 28 analyst reports since July 31, 2015 according to SRatingsIntel. The company was maintained on Wednesday, June 28 by Wells Fargo. As per Thursday, May 25, the company rating was upgraded by FBR Capital. The stock has “Neutral” rating by Credit Suisse on Friday, October 7. RBC Capital Markets maintained Metlife Inc (NYSE:MET) rating on Tuesday, January 19. RBC Capital Markets has “Outperform” rating and $65.0 target. The company was upgraded on Monday, June 27 by Sandler O’Neill. The company was maintained on Monday, June 5 by RBC Capital Markets. The stock of Metlife Inc (NYSE:MET) earned “Buy” rating by Wells Fargo on Wednesday, April 19. The stock of Metlife Inc (NYSE:MET) has “Equal-Weight” rating given on Wednesday, November 11 by Morgan Stanley. On Tuesday, January 5 the stock rating was downgraded by Citigroup to “Neutral”. Macquarie Research upgraded the stock to “Outperform” rating in Thursday, January 14 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.